| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $14.1M | -25.3% |
| SG&A Expense | $19.1M | +12.1% |
| Operating Income | -$36.2M | -0.6% |
| Net Income | -$35.6M | +0.6% |
| EPS (Basic) | -$1.66 | +1.8% |
| EPS (Diluted) | -$1.66 | +1.8% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $17.3M | +29.5% |
| Short-term Investments | $21.8M | -56.6% |
| Current Assets | $39.7M | -40.9% |
| Total Assets | $39.7M | -42.6% |
| Current Liabilities | $3.7M | -8.8% |
| Total Liabilities | $3.7M | -9.0% |
| Stockholders' Equity | $36.0M | -44.7% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$22.9M | +27.4% |
| Capital Expenditures | $308K | -36.9% |
| Investing Cash Flow | $27.0M | +150.7% |
| Financing Cash Flow | -$139K | -120.0% |
| Free Cash Flow | -$23.2M | +27.5% |